Clinicopathological features of homologous recombination deficient epithelial ovarian cancers: sensitivity to PARP inhibitors, platinum and survival

Mukhophadyay, Asima and Plummer, Elizabeth R and Elattar, Ahmed and San, SooHoo and Uzir, Bisha Fathamah and Quinn, Jennifer E and Edmondson, Richard J and Curtin, Nicola J and Harriet, Aneke and Maxwell, Perry and McCluggage, W Glenn (2012) Clinicopathological features of homologous recombination deficient epithelial ovarian cancers: sensitivity to PARP inhibitors, platinum and survival. Cancer Research, 72 (22). pp. 5675-5682. ISSN 1538-7445 (O), 0008-5472 (P) (Unpublished)

PDF - Published Version Restricted to Repository staff only Download (441kB) | Request a copy

Abstract

Up to 50% of epithelial ovarian cancers (EOC) display defects in the homologous recombination (HR) pathway. We sought to determine the ramifications of the homologous recombination deficient (HRD) status on the clinicopathological features, chemotherapy response and survival outcomes of EOC patients. HR status was determined in primary cultures from ascitic fluid in 50 chemotherapy naïve patients by a functional RAD51 immunofluorescence assay and correlated with in vitro sensitivity to the PARP inhibitor (PARPi), rucaparib. All patients went on to receive platinum based chemotherapy; platinum sensitivity, tumor progression and overall survival were compared prospectively in HR competent vs. HR deficient patients. Compared to HR competent patients, the HRD group was predominantly serous with a higher median CA125 at presentation. HRD was associated with higher ex vivo PARP inhibitor sensitivity and clinical platinum sensitivity. Median follow up duration was 14 months; patients in the HRD group had lower tumor progression rates at 6 months, lower overall /disease specific death rates at 12 months and higher median survival. We therefore suggest that HRD as predicted by a functional RAD51 assay correlates with in vitro PARPi sensitivity, clinical platinum sensitivity and improved survival outcome.

Item Type:	Article (Journal)
Additional Information:	5634/33769
Uncontrolled Keywords:	epithelial ovarian cancers (EOCs)
Subjects:	R Medicine > RB Pathology R Medicine > RG Gynecology and obstetrics
Kulliyyahs/Centres/Divisions/Institutes (Can select more than one option. Press CONTROL button):	Kulliyyah of Pharmacy > Department of Pharmaceutical Chemistry
Depositing User:	Asst. Prof Bisha Uzir
Date Deposited:	04 Sep 2015 16:18
Last Modified:	04 Sep 2015 16:18
URI:	http://irep.iium.edu.my/id/eprint/33769

Actions (login required)

View Item